Oncology Clinical Trials in Eugene, OR
As of August 2026, 50 paid clinical trials are recruiting for Oncology in Eugene, Oregon. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
50 clinical trials for Oncology
·Clear filters·A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Long-term Extension Study of PCI-32765 (Ibrutinib)
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
MYLUNG Consortium Part 3: Observational Study
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Top Research Study Locations in Eugene
Researchers run research studies in Eugene, OR at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Willamette Valley Cancer Institute and Research Center | Breast Cancer, Carcinoma, Non-Small-Cell Lung, Chronic Myeloid Leukemia | 13 |
| Oncology Associates of Oregon, P.C. | Advanced/Metastatic Non-Small Cell Lung Cancer, Advanced/Metastatic Urothelial Cancer, Breast Cancer | 11 |
| University of Oregon | Acculturative Stress, Aging, Autism Spectrum Disorder | 10 |
| Oncology Associates of Oregon | Multiple Myeloma, Breast Neoplasms, Endometrial Cancer | 8 |
| Verum Research, LLC | Diabetic Macular Edema, DME, Diabetic Macular Edema (DME) | 7 |
| Willamette Valley Cancer Institute | Acute Myeloid Leukemia (AML), Breast Neoplasms, Low Grade Serous Ovarian Cancer | 5 |
| Chestnut Health Systems | Decision Making, Decision Making, Shared, Implementation Science | 3 |
| Oncology Associates Of Oregon, Pc | Non-small Cell Lung Cancer (NSCLC), Solid Tumors, Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma | 3 |
| Prevention Science Institute | Academic Achievement, Behavior Problems, Clinical High Risk for Psychosis (CHR) | 3 |
| Verum Research LLC | Age-related Macular Degeneration (AMD), Epiretinal Membrane, Geographic Atrophy | 3 |
| Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) | Lung Neoplasm Malignant, Cervical Cancer, Fallopian Tube Cancer | 3 |
| Oncology Associates of Oregon PC | Early Breast Cancer, NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer) | 2 |
| Oncology Associates of Oregon PC Willamette Valley Cancer Institute | Carcinoma, Non-Small-Cell Lung, Multiple Myeloma | 2 |
| Oncology Associates of Oregon Willamette Valley Cancer Center | Chronic Lymphocytic Leukemia, CLL, Small Lymphocytic Lymphoma | 2 |
| Oncology Associates of Oregon, P.C | B-Cell Non-Hodgkins Lymphoma, Breast Cancer | 2 |
| Pacific Clear Vision Institute | Astigmatism, Bacterial Keratitis, Ectasia of Cornea | 2 |
| Pacific Sports & Spine | Degenerative Conditions of the Lumbar Spine, Degenerative Disc Disease, Disc Degeneration | 2 |
| Pacific Sports and Spine | Degenerative Disc Disease, Osteoarthritis Knee Pain | 2 |
| Pacific Sports and Spine, LLC | Chronic Pain, Pain | 2 |
| Slocum Research & Education Foundation | Avascular Necrosis, Dislocation, Hip, Femoral Neck Fractures | 2 |
| Willamette Valley Cancer Institute and Research Center - Eugene | Endometrial Cancer, Extensive Stage Small-cell Lung Cancer, Recurrent or Progressive Endometrial Cancer | 2 |
| Williamette Valley Cancer Institute and Research Center | Non-small Cell Lung Cancer (NSCLC), Urinary Bladder Neoplasms, Urothelial Cancer | 2 |
| 517 | Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer | 1 |
| AURORA-1 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| AURORA-2 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
Active & Upcoming Studies in Eugene (2026)
Recruiting trials in Eugene grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (61 active studies)
- A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma · Phase 2 · SCRI Development Innovations, LLC
- A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer · Phase 3 · AbbVie
Eye & vision (10 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
Mental health & behavior (7 active studies)
- Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services · University of Oregon
- Testing Implementation Strategies to Scale-up a Multicomponent Continuum of Service Intervention for Families Involved in Systems With Parental Opioid and Methamphetamine Use · Chestnut Health Systems
Neurology & pain (5 active studies)
- Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain · Phase 3 · Saol Therapeutics Inc
- Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease · VIVEX Biologics, Inc.
Diabetes & metabolic (4 active studies)
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
Pediatric (2 active studies)
- Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services · University of Oregon
- Walk With Me (WWM) for Perinatal Grief · Oregon Research Behavioral Intervention Strategies, Inc.
Common conditions studied in Eugene
- Endometrial Cancer (8 active studies)
- Multiple Myeloma (6 active studies)
- Chronic Lymphocytic Leukemia (5 active studies)
- Fallopian Tube Cancer (4 active studies)
- Ovarian Cancer (4 active studies)
- Breast Cancer (3 active studies)
Leading research sponsors in Eugene
- University of Oregon
- AbbVie
- Pfizer
- Eli Lilly and Company
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Eugene?
There are approximately 129 recruiting clinical trials in Eugene, Oregon listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Eugene pay participants?
Most recruiting trials in Eugene compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Eugene?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Eugene?
The most common conditions under active study in Eugene include Endometrial Cancer (8), Multiple Myeloma (6), Chronic Lymphocytic Leukemia (5), Fallopian Tube Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Eugene?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Eugene on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Eugene?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Eugene?
Recruiting research sites in Eugene include Willamette Valley Cancer Institute and Research Center, Oncology Associates of Oregon, P.C., University of Oregon, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Eugene right now?
The largest active categories in Eugene are Cancer & tumors (61), Eye & vision (10), Mental health & behavior (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.